London-based Vira Health has secured over £9 million in investments to upgrade its app with new services. The digital health company, which is responsible for Stella, a subscription-based app that supports women through menopause, will use the money to add telehealth and prescriptions to the app, as well as to fund clinical trials.
Andrea Berchowitz, co-founder and CEO of Vira Health said: “Better menopause care is crucial in the fight for gender equity in the workplace. The Stella app offers women a highly personalised, completely private and always-on treatment option. It is designed for a diversity of companies wanting to expand their employee benefit schemes. Our focus is onboarding more employers to Stella this year.”
According to a study by Vodafone, 60 per cent of women across five countries said that menopausal symptoms impacted their work, with 30 per cent in the UK alone missing work due to menopausal symptoms. 11 per cent declined a promotion and 8 per cent resigned from their jobs.
The Stella app combines evidence-based treatments and currently gives women personalised treatments based on their symptoms. Treatments include cognitive behavioural therapy, pelvic floor exercises, and diet and lifestyle changes which are tailored to each individual. It also provides access to menopause experts, guided meditation, educational materials, exercises, recipes and online classes.
The money for the upgrade has been secured in a funding round led by Octopus Ventures with participation from Optum Ventures as well as existing investors.
Kamran Adle, a health investor from Octopus Ventures, said: “Menopause is an enormous yet underserved and underfunded market. One billion women, or approximately 12 per cent of the global population, are expected to experience menopause by 2025, and we’re excited to work with the Vira Health team.”